We are live on ! Find out more
VYNT

Vyant Bio, Inc. Common Stock
VYNT

Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

18 hedge funds and large institutions have $2.96M invested in Vyant Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

177% more capital invested

Capital invested by funds: $1.06M → $2.96M (+$1.89M)

80% more funds holding

Funds holding: 10 → 18 (+8)

Holders
18
Holders Change
+8
Holders Change %
+80%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$648K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$347K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$295K
4
NA
NewEdge Advisors
Louisiana
+$284K
5
Northern Trust
Northern Trust
Illinois
+$99.3K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$313K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$130K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$839K -$313K -12,375 -25%
BlackRock
2
BlackRock
New York
$764K +$648K +25,596 +349%
Vanguard Group
3
Vanguard Group
Pennsylvania
$396K +$347K +13,686 +401%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$270K +$295K +11,661 New
NA
5
NewEdge Advisors
Louisiana
$260K +$284K +11,203 New
VF
6
Virtu Financial
New York
$182K +$96.5K +3,809 +94%
Northern Trust
7
Northern Trust
Illinois
$91K +$99.3K +3,920 New
QC
8
QCM Cayman
Texas
$50K +$54.6K +2,157 New
Citigroup
9
Citigroup
New York
$46K +$50.7K +2,000 New
CCT
10
Country Club Trust
Missouri
$45K – – –
US Bancorp
11
US Bancorp
Minnesota
$4K +$4.05K +160 New
UBS Group
12
UBS Group
Switzerland
$4K +$4.13K +163 New
Osaic Holdings
13
Osaic Holdings
Arizona
$2K – – –
Morgan Stanley
14
Morgan Stanley
New York
$1K +$1.17K +46 +657%
TRCT
15
Tower Research Capital (TRC)
New York
$1K +$1.52K +60 New
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
– -$130K -9,413 Closed
EP
17
Eudaimonia Partners
Tennessee
– +$152 +6 New
Wells Fargo
18
Wells Fargo
California
– +$253 +10 +200%

VYNT Hedge Fund Activity: Q1 2021 in Review

18 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio, Inc. Common Stock (VYNT) for Q1 2021, worth a combined $2.96M — up 177% from $1.06M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VYNT positions and 1 closed out — a net gain of 8 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, adding an estimated $648K. The largest seller was Renaissance Technologies, cutting an estimated $313K.

  • 18 institutional investors held Vyant Bio, Inc. Common Stock (VYNT) as of Q1 2021, up from 10 in Q4 2020.
  • Funds reported $2.96M of Vyant Bio, Inc. Common Stock stock for Q1 2021, up 177% quarter-over-quarter.
  • 9 funds opened new Vyant Bio, Inc. Common Stock positions in Q1 2021 and 1 closed out, a net change of +8 holders.
  • The largest Vyant Bio, Inc. Common Stock buyer in Q1 2021 was BlackRock, an estimated $648K added.
  • The largest Vyant Bio, Inc. Common Stock seller in Q1 2021 was Renaissance Technologies, an estimated $313K sold.

Based on aggregated 13F filings for Q1 2021.